✦ LIBER ✦

Modeling the Probability That Ashkenazi Jewish Women Carry a Founder Mutation in BRCA1 or BRCA2

✍ Scribed by John L. Hopper; Mark A. Jenkins

Book ID: 119769995
Publisher: American Society of Human Genetics
Year: 1999
Tongue: English
Weight: 514 KB
Volume: 65
Category: Article
ISSN: 0002-9297
DOI: 10.1086/302674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency of premature menopause in wome

Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation

✍ Finch, Amy; Valentini, Adriana; Greenblatt, Ellen; Lynch, Henry T.; Ghadirian, P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Validation study of the lambda model for

Validation study of the lambda model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women

✍ C Apicella; JG Dowty; GS Dite; MA Jenkins; RT Senie; MB Daly; IL Andrulis; EM Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

The Jewish Ashkenazi Founder Mutations i

The Jewish Ashkenazi Founder Mutations in the BRCA1/BRCA2 Genes Are Not Found at an Increased Frequency in Ashkenazi Patients with Prostate Cancer

✍ Ayala Hubert; Tamar Peretz; Orly Manor; Luna Kaduri; Naomi Wienberg; Israela Ler 📂 Article 📅 1999 🏛 American Society of Human Genetics 🌐 English ⚖ 68 KB

Subjective and Objective Risks of Carryi

Subjective and Objective Risks of Carrying a BRCA1/2 Mutation in Individuals of Ashkenazi Jewish Descent

✍ Kimberly Kelly; Howard Leventhal; Deborah Toppmeyer; Judy Much; James Dermody; M 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 142 KB

Molecular testing for the BRCA1 and BRCA

Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveys

✍ Tafe, Laura J.; Datto, Michael B.; Palomaki, Glenn E.; Lacbawan, Felicitas L. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 618 KB

Prophylactic salpingo-oophorectomy in a

Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation

✍ Fatima Laki; Youlia M. Kirova; Pascale This; for the IC-BOCRSG ; Corinne Planche 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract ## BACKGROUND. Prophylactic salpingo‐oophorectomy (SO), which is recommended in __BRCA1/2__ mutation carriers, still needs to be reappraised. ## METHODS. In all, 89 __BRCA1/BRCA2__ mutation carriers underwent SO between 1994–2004. Past medical and familial history, SO, results and su